Suppliers / Jiangsu Xidi Pharmaceuticals

Jiangsu Xidi Pharmaceuticals

China Updated 9 July 2026

Jiangsu Xidi Pharmaceuticals is an API manufacturer based in China. It holds 2 active US drug master files and one valid CEP across a filed portfolio of 7 molecules.

2
active US DMFs
1
valid CEPs
2
registered plants 1 with an FDA FEI number
10
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026.

Registered plants

Site FDA FEI
Qidong, China Not on file
China, China 3013431774

What they file, and where

Molecule Regulators Docs
Nilotinib SFDA (Saudi Arabia) 3
Abiraterone SFDA (Saudi Arabia) 1
Cabazitaxel US FDA 1
Carfilzomib US FDA 1
Irinotecan EDQM 1
Lapatinib Ditosylate SFDA (Saudi Arabia) 1
Lenvatinib SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Cabazitaxel API Carfilzomib API Irinotecan API Lenvatinib API Nilotinib API Abiraterone API

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 10 None

Questions about Jiangsu Xidi Pharmaceuticals

Does Jiangsu Xidi Pharmaceuticals hold a US DMF or a CEP?
Jiangsu Xidi Pharmaceuticals holds 2 active US drug master files and 1 valid CEP. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Jiangsu Xidi Pharmaceuticals FDA-registered?
One site operated by Jiangsu Xidi Pharmaceuticals carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
Where does Jiangsu Xidi Pharmaceuticals manufacture?
2 registered sites are on record, in China (Qidong and China). Every site is listed on this page with the register it came from.
What does Jiangsu Xidi Pharmaceuticals make?
7 molecules are on record against Jiangsu Xidi Pharmaceuticals, including Nilotinib, Abiraterone, Cabazitaxel and Carfilzomib. Each links through to that molecule's full manufacturer list.
Where does Jiangsu Xidi Pharmaceuticals file?
Filings are on record with MINSA (CR), 10 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Jiangsu Xidi Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Hetero shares 5 molecules MSN Laboratories shares 4 molecules Dr Reddy's Laboratories shares 4 molecules Shilpa Pharma Lifesciences shares 4 molecules Laurus Labs shares 3 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability